Study Evaluating the Efficacy and Safety With CD19CAR-T for Relapsed or Refractory Non-Hodgkin Lymphoma

Inclusion Criteria: 1. Diagnosis with Relapsed or refractory Non Hodgkin Lymphoma with CD19 positive 2. Age 18 to 65 years old, both male and female; 3. Is expected to survive more than 12 weeks; 4. Physical condition is good: 0-1 score ECOG score; 5. No obvious abnormal heart, liver, kidney, no large wounds that haven't healed on the body; 6. Into groups to participate in voluntarily, good adherence, can cooperate test observation, childbearing age women must be 7 days before starting treatment expert pregnancy test and the results were negative, and signed a written informed consent form. Exclusion Criteria: 1. Organ failure, such as heart: Class III and IV; liver: to Child grading of liver function grade C; kidney: kidney failure and uremia stage; lung: symptoms of severe respiratory failure; brain: disorder of consciousness; 2. Existing serious acute infection, uncontrollable, or have fester sex and chronic infection, wound in delay no more; 3. Pregnancy and lactation women; 4. Patients who have participated in other clinical trials or other clinical trials in the past 30 days; 5. The Investigator believe the patients should not participate in this experiment.